(주)쎌코 / CELLKOR INC.
CELLKOR INC.'s KOBDi Score is 39.55 as of Sep 2026, up 0.32 points since Apr 2025; it rose in 2 of the 12 monthly updates and never fell. As of Sep 2026 it is ahead of about 45% of companies in its industry, against 45% in Aug 2026 and 12% in Apr 2025. Its strongest position was 45% (Sep 2026) and its weakest 11% (Jul 2025).
A year earlier, in Aug 2025, its score was 39.39 and it was ahead of about 12% of companies in its industry.
| Sep 2026 | 39.55 | ahead of 45% |
| Aug 2026 | 39.55 | ahead of 45% |
| Jul 2026 | 39.39 | ahead of 45% |
| Jun 2026 | 39.39 | ahead of 44% |
| May 2026 | 39.39 | ahead of 45% |
| Apr 2026 | 39.39 | ahead of 45% |
| Mar 2026 | 39.39 | ahead of 45% |
| Feb 2026 | 39.39 | ahead of 45% |
| Dec 2025 | 39.39 | ahead of 45% |
| Aug 2025 | 39.39 | ahead of 12% |
| Jul 2025 | 39.23 | ahead of 11% |
| May 2025 | 39.23 | ahead of 13% |
| Apr 2025 | 39.23 | ahead of 12% |
Where is CELLKOR INC. located?
CELLKOR INC. is registered at 서울특별시 구로구 디지털로26길, South Korea (postal code 08389).
What industry is CELLKOR INC. in?
CELLKOR INC. belongs to Manufacturing › Pharmaceuticals & Biologics › Manufacturing of medical supplies and other medicine-related products.
How many employees does CELLKOR INC. have?
CELLKOR INC. has 1–4 employees.
What is CELLKOR INC.'s KOBDi Score?
39.55 as of September 2026, ahead of about 45% of companies in its industry.
Who are CELLKOR INC.'s competitors?
Similar companies include KONG YOUNG, 주식회사성안산업 and Genie Dental.


